Drug Interaction Report

Atazanavir and Didanosine: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Atazanavir

Reyataz
+

Didanosine

Videx® Videx® EC
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 179 documented Atazanavir interactions, 134 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
established
Severity
Major

What happens

Reduced solubility and exposure to atazanavir with the didanosine buffered formulation and reduced didanosine exposure with enteric coated didanosine formulation

Interaction Deep Dive

Atazanavir solubility decreases as gastric pH increases. Exposure to atazanavir was markedly decreased when atazanavir and didanosine buffered tablets were coadministered. The decrease in exposure to atazanavir is likely due to the increase in gastric pH caused by buffers in the didanosine tablets. Didanosine enteric coated capsules simultaneously administered with atazanavir decreases didanosine exposure. Atazanavir should be given with food 2 hours before or 1 hour after didanosine buffered formulation or enteric-coated capsules1.

Why it happens (mechanism)

An unknown mechanism when administered with enteric coated didanosine; increase in gastric pH caused by buffers in the didanosine buffered formulation tablets

Literature reports

2 reports — tap to read

a) Simultaneous coadministration of didanosine buffered tablets with an atazanavir appeared to significantly reduce the serum plasma level of atazanavir. Didanosine buffered tablets 200 mg plus stavudine 40 mg administered simultaneously with atazanavir 400 mg once daily in 31 subjects resulted in a significant decline in Cmax, AUC and Cmin by 89%, 87% and 84% respectively 1.

b) Simultaneous coadministration of atazanavir and didanosine enteric coated capsules significantly decreased the serum plasma levels of didanosine. Didanosine 400 mg given administered simultaneously with atazanavir 400 mg once daily with food resulted in a decline in Cmax and AUC by 36% and 34%, respectively and an increase in Cmin by 13%. Alternatively, didanosine 400 mg given with or without food once daily administered simultaneously with atazanavir 300 mg plus ritonavir 100 mg once daily resulted in a decline in Cmax and AUC by 38% and 34%, respectively and an increase in Cmin by 25% 1.

Common questions

Can I take Atazanavir and Didanosine together?

Reduced solubility and exposure to atazanavir with the didanosine buffered formulation and reduced didanosine exposure with enteric coated didanosine formulation Always confirm with your pharmacist or prescriber before making any change.

How serious is the Atazanavir and Didanosine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Questions for your pharmacist

  • Does my dose of Atazanavir or Didanosine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: REYATAZ(R) oral capsules, oral powder, atazanavir oral capsules, oral powder. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2020. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.